Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Very late restenosis after paclitaxel-eluting stent implantation.

    Cosgrave J, Qasim A, Latib A, Aranzulla TC, Colombo A.

    Ann Intern Med. 2007 Dec 18;147(12):885-7. No abstract available. PMID: 18087066 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents.

    Tsuchida K, Ong AT, Aoki J, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sianos G, Regar E, McFadden EP, van der Giessen WJ, de Feyter PJ, de Jaegere PP, van Domburg RT, Serruys PW.

    Am J Cardiol. 2005 Aug 1;96(3):395-8.PMID: 16054466 [PubMed - indexed for MEDLINE]Related articles

    3.

    Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients).

    Cherradi R, Ouldzein H, Zouaoui W, Elbaz M, Puel J, Carrié D.

    Arch Cardiovasc Dis. 2008 Jan;101(1):11-7.PMID: 18391867 [PubMed - indexed for MEDLINE]Related articles

    4.

    Crush stenting with paclitaxel-eluting or sirolimus-eluting stents for the treatment of coronary bifurcation lesions.

    Chen S, Zhang J, Ye F, Zhu Z, Lin S, Tian N, Liu Z, Fang W, Chen Y, Sun X, Kwan TW.

    Angiology. 2008 Aug-Sep;59(4):475-83. Epub 2008 Apr 2.PMID: 18388098 [PubMed - indexed for MEDLINE]Related articles

    5.

    Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.

    Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA.

    Catheter Cardiovasc Interv. 2008 Apr 1;71(5):629-35.PMID: 18360855 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions.

    Ruef J, Störger H, Schwarz F, Haase J.

    Catheter Cardiovasc Interv. 2008 Feb 15;71(3):333-9.PMID: 18288747 [PubMed - indexed for MEDLINE]Related articles

    7.

    Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry.

    Buszman P, Trznadel S, Milewski K, Rzeźniczak J, Przewłocki T, Kośmider M, Wójcik J, Janczak J, Zurakowski A, Kondys M, Król M, Kinasz L, Jaklik A, Rzeszutko Ł, Kałuza GL, Kiesz S, Gil R.

    Catheter Cardiovasc Interv. 2008 Jan 1;71(1):51-7.PMID: 18098182 [PubMed - indexed for MEDLINE]Related articles

    8.

    Drug-eluting stents for saphenous vein graft lesions: the limits of evidence.

    Bittl JA.

    J Am Coll Cardiol. 2009 Mar 17;53(11):929-30. No abstract available. PMID: 19281921 [PubMed - indexed for MEDLINE]Related articles

    9.

    Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?

    Shaikh F, Maddikunta R, Djelmami-Hani M, Solis J, Allaqaband S, Bajwa T.

    Catheter Cardiovasc Interv. 2008 Apr 1;71(5):614-8.PMID: 18360853 [PubMed - indexed for MEDLINE]Related articles

    10.

    Stent strut fracture: seeing is believing.

    Carter AJ.

    Catheter Cardiovasc Interv. 2008 Apr 1;71(5):619-20. No abstract available. PMID: 18360854 [PubMed - indexed for MEDLINE]Related articles

    11.

    30-year patency of a saphenous vein graft in coronary bypass graft surgery.

    Ozcan AV, Evrengul H, Goksin I, Gur S, Kaftan A.

    Ann Thorac Surg. 2008 Apr;85(4):e23. No abstract available. PMID: 18355484 [PubMed - indexed for MEDLINE]Related articles

    12.

    Successful local antiproliferative paclitaxel delivery in a repeatedly restenosed lesion of the right coronary artery after drug eluting-stent implantation.

    Herdeg C, Göhring-Frischholz K, Helber U, Geisler T, May A, Haase KK, Gawaz M.

    Clin Res Cardiol. 2008 Jan;97(1):49-52. Epub 2007 Nov 22. No abstract available. PMID: 18026704 [PubMed - indexed for MEDLINE]Related articles

    13.

    A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus.

    Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Hong MK, Rhee KS, Chae JK, Ko JK, Park JH, Lee JH, Choi SW, Jeong JO, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Kim HS, Park SJ.

    J Am Coll Cardiol. 2008 Aug 26;52(9):727-33.PMID: 18718419 [PubMed - indexed for MEDLINE]Related articles

    14.

    Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.

    Flores-Ríos X, Marzoa-Rivas R, Abugattás-de Torres JP, Piñón-Esteban P, Aldama-López G, Salgado-Fernández J, Calviño-Santos R, Vázquez-Rodríguez JM, Vázquez-González N, Castro-Beiras A.

    Am Heart J. 2008 Apr;155(4):648-53. Epub 2008 Feb 21.PMID: 18371471 [PubMed - indexed for MEDLINE]Related articles

    15.

    "Candy wrapper" effect after drug-eluting stent implantation: déjà vu or stumbling over the same stone again?

    Angiolillo DJ, Sabatá M, Alfonso F, Macaya C.

    Catheter Cardiovasc Interv. 2004 Mar;61(3):387-91.PMID: 14988901 [PubMed - indexed for MEDLINE]Related articles

    16.

    Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.

    Schrale RG, van Gaal W, Banning A.

    Heart Lung Circ. 2007 Oct;16(5):378-9. No abstract available. PMID: 18027454 [PubMed - indexed for MEDLINE]Related articles

    17.

    Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention.

    Solinas E, Dangas G, Kirtane AJ, Lansky AJ, Franklin-Bond T, Boland P, Syros G, Kim YH, Gupta A, Mintz G, Fahy M, Collins M, Kodali S, Stone GW, Moses JW, Leon MB, Mehran R.

    Am J Cardiol. 2008 Aug 1;102(3):311-5. Epub 2008 May 24.PMID: 18638592 [PubMed - indexed for MEDLINE]Related articles

    18.

    Percutaneous unprotected left main angioplasty with drug-eluting stents in a nonagenarian: feasible and safe despite recurrent restenosis.

    Sillano D, Moretti C, Biondi-Zoccai G, Sheiban I.

    Minerva Cardioangiol. 2008 Feb;56(1):167-70.PMID: 18432178 [PubMed - indexed for MEDLINE]Related articles

    19.

    Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.

    Zellweger MJ, Kaiser C, Brunner-La Rocca HP, Buser PT, Osswald S, Weiss P, Mueller-Brand J, Pfisterer ME; BASKET Investigators.

    J Nucl Med. 2008 Apr;49(4):550-6. Epub 2008 Mar 14.PMID: 18344439 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.

    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ; SPIRIT III Investigators.

    JAMA. 2008 Apr 23;299(16):1903-13.PMID: 18430909 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data